BARCELONA AND ME

Local Organizers

Gemma Vilahur, Barcelona

Chair, Eurothrombosis 2018
View CV  

Lina Badimon, Barcelona

Vice-Chair, Eurothrombosis 2018
View CV  

Nucleus Members of the Working Group of Thrombosis

Bianca Rocca, Italy

Chairperson

Bianca Rocca, MD, PhD is Professor of Pharmacology at the Catholic University School of Medicine in Rome (Italy). Prof. Rocca trained as Postdoctoral Fellow at the Center for Experimental Therapeutics, University Pennsylvania of Philadelphia (USA) with Prof. Garret A. FitzGerald. Prof. Bianca Rocca is Chairperson of the Working Group on Thrombosis of the European Society of Cardiology, is member of the Board of the Clinical Pharmacology section of the Italian Society of Pharmacology, of the Board of the Italian Group of Atherosclerosis, Thrombosis and Vascular Biology and she is listed in the Top Italian Scientists. She is member of the Editorial Board of the European Heart Journal-Cardiovascular Pharmacology, Pharmacology Research & Perspectives and Diabetes and Vascular Disease Research. She has been member of different Task Forces for ESC documents including guideline and position papers. She has co-authored over 100 articles, with over 6200 citations in peer-reviewed journals, including top journals such as: Annals of Internal Medicine, Atherosclerosis Thrombosis Vascular Biology, Blood, Circulation, Clinical Pharmacology and Therapeutics, European Heart Journal, Diabetes, Journal of the American College of Cardiology, Journal of Clinical Investigation, Nature Clinical Practice in Cardiovascular Medicine, Nature Medicine, Science, Proceedings of the National Academy of Science (USA). Her H-index is 40. Main scientific topics of interest are antiplatelet drugs, eicosanoids, primary haemostasis, platelets, non-steroidal anti-inflammatory drugs, anti-thrombotic prophylaxis of cardiovascular diseases.

Dirk Sibbing, Germany

Vice-chair

Joao Morais, Portugal

Past-chairperson

Gemma Vilahur, Barcelona

Treasurer

Dr. Gemma Vilahur is a Senior I3P Researcher at the Cardiovascular Science Institute (ICCC) of the Hospital de la Santa Creu i Sant Pau in Barcelona. Her translational research activities focus on ischemic heart disease, from atherothrombosis to cardioprotection. She has published 111 articles in peer reviewed journals in the cardiovascular field including original manuscripts, consensus and position papers, and reviews and has contributed to 27 book chapters (H-index: 26; total citations: 2248). She is part of the Editorial Board of prestigious Scientific Journals in the Cardiovascular Field (Cardiovascular Research, Vascular Phamacology, Cardiovascular Drugs and Therapy) and the author of three patents related with cardioprotection. Her previous appointments include: Post-doctoral fellowship from the Spanish Ministry of Economy and Competitiveness at the Cardiovascular Biology Research Laboratory, Zena and Michael A.Wiener Cardiovascular Institute at the Mount Sinai School Medicine, New York, USA (2004-2006); Juan de la Cierva Researcher at the Spanish Ministry of Science and Education, (2006-2009); Ramon y Cajal Researcher from the Science and Innovation Ministry of Spain (MICINN; 2009-2014).Awards and Honors: she has been awarded by the European Society of Cardiology – ESC [Berlin 2002, Vienna 2003, Vienna 2007, Munich 2008 (young investigation award), London 2015], she has received the First Prize in the National Congress of Cardiology (Madrid 2007; Seville 2012), First and second Prize in the National Congress of Atherosclerosis (Pamplona 2009 and Zaragoza 2013, respectively), the Northwestern Cardiovascular Young Investigator's Forum and the Arteriosclerosis, Thrombosis, and Vascular Biology Merit Award of the American Heart Association (AHA; Chicago 2006) and has been awarded by L’Oreal-UNESCO foundation - for Women in Science (2012). Positions of trust: she was elected Nucleus member of the Working Group of Thrombosis of the European Society of Cardiology (ESC; 2014-2018) and further became the treasurer of this Working Group (2016-2018). She is the founder of the Scientists of Tomorrow (2013-2016) working closely and under the umbrella of the Council of Basic Cardiovascular Science – European Society Cardiology.

Andrea Rubboli, Italy

Secretary

Andrea Rubboli is Senior Interventional cardiologist at the Division of Cardiology, Ospedale Maggiore, Bologna, Italy. After earning cum laude both his MD degree and specialization in Cardiology at the University of Bologna Medical School, Italy, he completed subsequent training at Loyola University of Chicago, IL, USA and University of Linköping, Sweden.Andrea Rubboli has long been interested in the diagnosis and treatment of thrombotic and thromboembolic diseases, both at the arterial and venous site. He carried out clinical studies on the diagnosis and treatment of acute pulmonary embolism, and served as Chairman of the Working Group on Diseases of the Pulmonary Circulation of the Italian Association of Hospital Cardiologists (ANMCO). He has pioneered the field of antithrombotic treatment of patients with indication for oral anticoagulation undergoing coronary stent implantation. On this issue, a substantial scientific contribution (also through national and international collaborations) has been produced, leading to the acquisition of international reputation, constant invitation as faculty member to the most important congresses, and involvement in the development of guidelines/international consensus documents. Andrea Rubboli has authored/co-authored 125 papers in peer-reviewed journals and has edited/co-edited two books on percutaneous coronary intervention in patients on oral anticoagulation. He is currently Secretary of the Working Group on Thrombosis of the European Society of Cardiology and President of the Italian Study Group on Atherosclerosis, Thrombosis and Vascular Biology (ATVB)

Bruna Gigante, Sweden

Ordinary nucleus member

Bruna Gigante graduated in Medicine (1994) and obtained the degree as specialist in Cardiology (1998) at the Federico II University in Naples, Italy. She has then been working about 3 years in Klaus Lindpaintner´s genetic epidemiology lab at Harvard Medical School, Boston, MA, USA as research fellow and thereafter pursued a PhD degree in Experimental Medicine (2002-2006) at the Federico II University in Naples. After graduation, Bruna moved to and has been working first as post doc (2007-2010) then as assistant professor (2011-2015) at the Unit of Cardiovascular Epidemiology at the Institute of Environmental Medicine (IMM) at Karolinska Institutet (KI). From 2012 Bruna has started working again actively as a clinician at the Department of Cardiology at Danderyd´s Hospital (Stockholm) and from December 2015 holds a position as senior lecturer in cardiovascular medicine, a position that combines clinical and research work. From 2017 she has been appointed research group leader at IMM and project leader for the KI-Makerere University (Uganda) collaboration to establish a novel cardiovascular cohort to identify clinical and biological risk markers for cardiometabolic diseases in Uganda. She has authored/co-authored some 100 scientific publications in peer-reviewed international journals. At present Bruna leads a research group 2 PhD students and 1 pre PhD student. Overarching aim of her research group´s line of research is to discover and validate biomarkers that can be used as independent predictors of cardiovascular events and to identify novel target for treatment. She has received funding from internal and external sources both as main applicant and as co-applicant. At present she is a member of the steering committee of the strategic research in epidemiology and of the cardiovascular research program at KI. She has been involved in several international collaborations both in large consortia and in multi-center studies that have resulted in publications in journals with medium/high impact factor. Bruna is involved in teaching as course leader and teacher in postdoctoral courses and courses for specialists in training. In addition, she has acted as supervisor of both graduate and undergraduate students

Diana Gorog, England

Ordinary nucleus member
View CV  

Diana Gorog, England

Ordinary nucleus member

Diana Gorog is Professor of Cardiovascular Medicine at University of Hertfordshire and Visiting Professor at the National Heart and Lung Institute, Imperial College, London, UK. She is a Consultant Cardiologist and Clinical Lead for Research at East and North Hertfordshire NHS Trust, UK. Prof. Gorog trained in medicine at St. Bartholomew’s Medical School, University of London, and undertook her cardiology training in central London teaching hospitals. She obtained a postgraduate MD from Imperial College and PhD from King’s College, London. In addition to being an interventional cardiologist, including undertaking PPCI on call, she is actively engaged in clinical research on thrombosis, in particular platelet function testing, endogenous fibrinolysis and thrombosis risk assessment.

Erik Grove, Denmark

Ordinary nucleus member
View CV  

Erik Grove, Denmark

Ordinary nucleus member

Dr Grove has specialised in Internal Medicine:Cardiology and in Thrombosis & Haemostasis. He is a clinical cardiologst at Aarhus University Hospital in Denmark and has a PhD in platelet function testing and platelet turnover in coronary artery disease. He works in a thrombosis clinic and also with cardiac CT. Other areas of interest include antithrombotic therapy, acute cardiac care, diabetes mellitus, atrial fibrillation and oral anticoagulants, including warfarin, self-monitored anticoagulant therapy, DOACS, switching, and drug-drug interactions. He is an author/co-author of >140 publications, and his research include laboratory studies, clinical studies and registry-based pharmaco-epidemiology.

Jolanta Siller-Matula, Austria

Ordinary nucleus member

Jolanta Siller-Matula, MD PhD, is Assoc. Professor at the Department of Cardiology at the Medical University of Vienna. As a PhD student, she carried out research on thrombin effects in vivo and in vitro at the Department of Clinical Pharmacology (Supervisor: Prof. Bernd Jilma). Thereafter, she expanded her research to fields of arterial thrombosis and personalized antiplatelet therapy (Department of Cardiology at the Medical University of Vienna), where she also leads the study group on Antithrombotic Treatment in Cardiovascular Indications. She is a (co-) author of > 80 peer-review articles with more than 4000 citations (h-index 32). Her publications have added to a debate in the cardiology community surrounding the efficacy and safety of conventional antiplatelet treatment and response variability to platelet inhibitors. She described the link between high platelet reactivity to clopidogrel and ischemic risk, the correlation between clinical factors and platelet reactivity, the effect of genetic polymorphisms and drug-drug interactions on the pharmacodynamics of antiplatelet drugs and clinical outcomes in patients with cardiovascular disease, and characterized von Willebrand Factor aptamers ARC15105 and ARC1779.

Walter Speidl, Austria

Ordinary nucleus member

Education and Academic Career. 1983 - 1987 Secondary school, Traun, Austria. 1987 - 1992 Technical college for electronics, Leonding, Austria. 1993 - 2000 Medical studies, University of Vienna. February 2011. University teaching thesis. October 2012 - Associate Professor, Internal Medicine Employments. 2000 - 2003 Research fellowship, University of Vienna, Department of Internal Medicine II. 2003 – 2006 and Residency, Medical University of Vienna, 2008 – 2011. Department of Internal Medicine II. 2006 – 2008 Research fellowship, The Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY. 2011 - 2014 Fellowship for cardiology and intensive care medicine. Medical University of Vienna, Department of Internal Medicine II. February 2014 - Deputy head of the cardiac critical care unit Main Fields of Innate immune system. Research Inflammation and thrombosis in atherosclerosis. Monocytes and macrophages in inflammatory diseases. Fibrinolytic system. Biomarkers in cardiology and critical care medicine. Publications. More than 70 Publications in medical journals with peer review Impact factor > 300, h-index 24 .Reviewer Atherosclerosis Cardiovascular Research European Heart Journal JACC. PLOS One Thrombosis and Haemostasis. Memberships. Austrian Society of Cardiology since 2004 in Medical Societies Vice chairman of the working group “Intensive care medicine”. European Society of Cardiology since 200. Member of the WG nucleus “Thrombosis”. American Heart Association since 2008. Austrian Society of Internal Medicine since 2012. European Atherosclerosis Society since 2013. Austrian Atherosclerosis Society since 2014. Academic Awards ISFP Special Achievement Award 2004. Award of the Austrian Society of Cardiology 2004 – Basic. Award of the Austrian Society of Cardiology 2005 – Clinical Researcher of the month Dezember 2011, Medical University of Vienna. Award of the Austrian Society of Cardiology 2012 – Basic Carl. S. Apstein Award 2012

Jean-Philippe Collet

Ex-officio member

Sigrun Halvorsen

Ex-officio member

Sigrun Halvorsen (MD, PhD, FESC) is Professor at the University of Oslo and Head of the Department of Cardiology, Oslo University Hospital Ulleval. Professor Halvorsen is a clinical cardiologist with a special interest in acute coronary syndrome (ACS) and antithrombotic treatment. She defended her Thesis in the field of basic coagulation/fibrinolysis in 1995, was certified as a specialist in Internal Medicine in 1997 and as a Cardiologist in 2000. Since September 2013 she has held the position as Head of Cardiology at Oslo University Hospital Ulleval, one of the largest cardiology departments in Norway. She has published over 120 scientific papers with over 8000 citations in peer-reviewed journals and has been the supervisor for many PhD students. Halvorsen is a Fellow of the European Society of Cardiology (FESC) since 2008 and a member of several ESC working groups and associations. In 2012-2016 she served as a Nucleus Member of the ESC Working Group on Thrombosis, and at present she is Board member of the ESC Acute Cardiac Care Association. She has also participated in several of the Task Forces for ESC Clinical Practice Guidelines (e. g. STEMI-guidelines 2012 and 2017), and is a frequently invited speaker to national and international congresses.

Robert F. Storey

Ex-officio member

Professor Robert Storey is Professor of Cardiology at the University of Sheffield, Sheffield, UK, where he has headed a thrombosis research group since 2002 and is director of the Cardiovascular Research Unit. In addition, Prof. Storey is Academic Director and honorary Consultant Cardiologist for the Cardiology and Cardiothoracic Surgery Directorate, Sheffield Teaching Hospitals NHS Foundation Trust. He has a special interest in the management of ischaemic heart disease, including acute coronary syndromes and coronary intervention. He served as a member of the executive committees for the DISPERSE2, PLATO and PEGASUS-TIMI 54 studies, leading the platelet function substudies for these trials, and of the steering committees for the TRA-CER, EPICOR and ATLANTIC studies. He is currently a member of the steering committees for the COMPLETE, RAPID CTCA, SENIOR RITA, AUGUSTUS and CLEAR SYNERGY studies. He was Chair of the Working Group on Thrombosis of the European Society of Cardiology (ESC) from 2012-2014 and has been a Task Force member for several ESC guidelines on non-ST-elevation acute coronary syndromes (2011 and 2015) and dyslipidaemias (2011).

Johann Wojta

Affiliated member

Johann Wojta, PhD, is Associate Professor of Medical Physiology at the Medical University of Vienna, Head of Research at the Division of Cardiology and Head of Core Facilities. He obtained his PhD in Zoology in 1986 at the University of Vienna and since then has done research in the area of cardiovascular biology with a focus on atherosclerosis. He has published more than 290 papers in peer-reviewed journals and he has a Hirsh-index of 56 according to google scholar. He has been Nucleus Member of the ESC Working Group on Thrombosis from 2010 to 2014, an ex-officio Nucleus Member from 2015 to 2016 and is currently an affiliated Nucleus Member from 2017 to 2018.